Anthrax in Wildlife: Epidemiology, Diagnosis, and Outbreak Response

Introduction

Anthrax is a peracute to acute infectious disease caused by the Gram-positive, spore-forming bacterium Bacillus anthracis. While historically recognized as a zoonotic threat to livestock and humans, anthrax is fundamentally a soil-borne disease of herbivorous wildlife that perpetuates a spore-based transmission cycle in endemic ecosystems [1, 2]. The disease is characterized by rapid onset of septicemia, massive bacteremia, and sudden death, often with exudation of blood from natural orifices that contaminates the environment with highly resistant spores [3]. This review focuses exclusively on the veterinary and ecological dimensions of anthrax in wildlife populations, including epidemiology, diagnostic modalities, and outbreak response protocols. The discussion emphasizes the biophysical mechanisms of spore survival, host-pathogen interactions at the molecular level, and the operational logic of diagnostic algorithms and containment strategies.

Etiology and Spore Biology

Bacillus anthracis is a member of the Bacillus cereus sensu lato group. Its pathogenicity is primarily conferred by two large plasmids: pXO1 (182 kb) encoding the lethal toxin (LeTx) and edema toxin (EdTx) components, and pXO2 (96 kb) encoding the poly-D-glutamic acid capsule [4, 5]. The capsule inhibits phagocytosis, while the binary toxins disrupt host cell signaling and induce vascular leakage [6].

The spore is the infectious morphotype. Sporulation occurs when vegetative bacilli are exposed to ambient oxygen, desiccation, and nutrient depletion, typically after the death and decomposition of a bacteremic host [7]. Spores are metabolically dormant, exhibit extreme resistance to heat, desiccation, ultraviolet radiation, and chemical disinfectants, and can remain viable in soil for decades [8, 9]. The spore coat is composed of multiple layers including an exosporium, a thick cortex of peptidoglycan, and a dehydrated core containing high concentrations of calcium dipicolinate [10]. Germination is triggered by specific amino acids and ribonucleosides present in the host's gastrointestinal or respiratory tract [11].

Epidemiology in Wildlife

Affected Species

Anthrax affects a broad range of mammalian species, but susceptibility varies markedly. Herbivores are the most susceptible, with ruminants, equids, and elephants being highly vulnerable [12]. In Africa, anthrax is a significant cause of mortality in species such as African elephants (Loxodonta africana), Cape buffalo (Syncerus caffer), zebras (Equus quagga), and various antelope species [13, 14]. In North America, bison (Bison bison), white-tailed deer (Odocoileus virginianus), and moose (Alces alces) are frequently affected [15, 16]. Carnivores and omnivores, including canids, felids, and suids, are relatively resistant, although they can become infected through ingestion of contaminated carcasses [17]. Vultures and other scavenging birds are highly resistant and play a role in spore dispersal [18].

Transmission Cycles

The transmission cycle is primarily indirect, through ingestion or inhalation of spores from contaminated soil, water, or vegetation [19]. Direct animal-to-animal transmission is rare because vegetative bacilli are rapidly killed by oxygen and desiccation outside the host [20]. Outbreaks are often associated with environmental triggers such as heavy rainfall followed by drought, which concentrates spores in soil and water sources, or soil disturbance from excavation or flooding [21, 22]. Insect vectors, particularly tabanid flies and blowflies, can mechanically transmit spores from carcasses to living animals, contributing to localized amplification [23].

Geographic Distribution

Anthrax is endemic in many regions worldwide, including sub-Saharan Africa, Central Asia, the Middle East, parts of South America, and North America [24]. In the United States, endemic foci exist in the Dakotas, Montana, Texas, and parts of the Mississippi River Valley [25]. The disease is sporadic in Europe and Australia, with occasional outbreaks linked to contaminated bone meal or imported animal products [26].

Pathogenesis

Following spore uptake, germination occurs in regional lymph nodes, where vegetative bacilli multiply and produce the antiphagocytic capsule and toxins [27]. The bacteria then enter the bloodstream, reaching concentrations exceeding 10^8 colony-forming units per milliliter of blood [28]. LeTx, a zinc metalloprotease, cleaves mitogen-activated protein kinase kinases (MAPKKs), disrupting intracellular signaling and inducing macrophage apoptosis [29]. EdTx, a calmodulin-dependent adenylate cyclase, elevates intracellular cyclic AMP levels, causing edema and impairing neutrophil function [30]. The combined effects lead to systemic vascular leakage, hypotension, hypoxia, and death within 24 to 72 hours in peracute cases [31].

Clinical Signs in Wildlife

Clinical signs are often absent in peracute cases, with animals found dead in good body condition [32]. In acute cases, observed signs include pyrexia, depression, ataxia, dyspnea, and bloody discharge from the mouth, nose, and anus [33]. Subacute cases may present with localized edema of the head, neck, or ventral thorax [34]. In resistant species such as pigs, a chronic, localized form characterized by pharyngeal lymphadenitis and edema is more common [35].

Diagnosis

Rapid and accurate diagnosis is critical for implementing control measures. Diagnostic approaches include microscopic examination, culture, molecular detection, and serology.

Microscopic Examination

Blood smears from freshly dead animals or tissue impression smears can be stained with polychrome methylene blue (M'Fadyean stain) to visualize characteristic square-ended, encapsulated bacilli in chains [36]. This method is rapid, inexpensive, and highly specific when performed by experienced personnel. However, sensitivity decreases in decomposed carcasses due to overgrowth of putrefactive bacteria [37].

Culture

Bacillus anthracis grows readily on sheep blood agar, producing non-hemolytic, ground-glass colonies with a characteristic "medusa head" morphology [38]. Selective media containing polymyxin B and lysozyme can be used to suppress contaminants [39]. Culture is the gold standard for confirmation but requires biosafety level 3 (BSL-3) facilities and is time-consuming (24-48 hours) [40].

Molecular Detection

Polymerase chain reaction (PCR) assays targeting plasmid-borne virulence genes (e.g., pagA on pXO1, capB on pXO2) and chromosomal markers (e.g., rpoB, BA5345) provide rapid, sensitive, and specific detection [41, 42]. Real-time PCR (qPCR) with hydrolysis probes allows quantification of bacterial load and can be performed directly on blood, tissue, or environmental samples [43]. Multiplex PCR panels can differentiate B. anthracis from other B. cereus group members [44]. Loop-mediated isothermal amplification (LAMP) assays have been developed for field-deployable diagnostics [45].

Serology

Serological assays, including enzyme-linked immunosorbent assay (ELISA) and Western blot, detect antibodies against protective antigen (PA) or lethal factor (LF) [46]. These methods are useful for retrospective surveillance and epidemiological studies but are not suitable for acute diagnosis due to the rapid course of disease [47].

Diagnostic Algorithm

The following Mermaid diagram outlines a decision tree for anthrax diagnosis in wildlife.

flowchart TD
    A[Dead animal found in endemic area], > B{Blood or tissue sample available?}
    B, >|Yes| C[Microscopy: M'Fadyean stain]
    C, > D{Encapsulated bacilli seen?}
    D, >|Yes| E[Presumptive positive: Initiate containment]
    D, >|No| F[PCR: pagA, capB, rpoB]
    F, > G{Positive for virulence genes?}
    G, >|Yes| E
    G, >|No| H[Culture on blood agar]
    H, > I{Non-hemolytic colonies?}
    I, >|Yes| J[Confirmatory PCR or MALDI-TOF]
    I, >|No| K[Rule out anthrax]
    B, >|No| L[Environmental sampling: soil, water]
    L, > F
    E, > M[Report to authorities]
    M, > N[Carcass disposal and decontamination]

Outbreak Response and Carcass Management

Immediate Actions

Upon confirmation of anthrax, the outbreak site must be quarantined to prevent animal movement and human access [48]. All carcasses must be disposed of on site to avoid spore dissemination. Incineration is the preferred method, as it destroys spores completely [49]. Burial is an alternative but must be performed in deep pits (at least 2 meters) lined with quicklime (calcium oxide) to inhibit spore germination [50]. Carcasses should not be opened or skinned, as this releases massive numbers of spores into the environment.

Decontamination

Contaminated soil and surfaces should be treated with 5% sodium hydroxide, 10% formalin, or 5% peracetic acid [51]. Sporicidal agents such as chlorine dioxide or hydrogen peroxide vapor are effective for equipment and facilities [52]. Vegetation in the affected area should be burned or removed.

Vaccination

In captive wildlife or high-value populations, vaccination with the Sterne strain (pXO1+, pXO2-) live spore vaccine can be used to protect at-risk animals [53]. Vaccination is not recommended during an active outbreak due to the incubation period required for immunity to develop [54].

Surveillance and Monitoring

Post-outbreak surveillance should include serological testing of surviving animals and environmental sampling to map spore distribution [55]. Geographic information systems (GIS) can be used to identify high-risk areas and predict future outbreaks based on soil type, rainfall, and animal density [56].

Conclusion

Anthrax remains a significant threat to wildlife populations in endemic regions, with the potential for large-scale mortality events that disrupt ecosystem dynamics and threaten endangered species. Effective management requires a multidisciplinary approach integrating epidemiological surveillance, rapid molecular diagnostics, and rigorous carcass disposal protocols. Advances in field-deployable PCR and LAMP technologies are improving diagnostic turnaround times, while computational models are enhancing predictive capabilities. Continued research into spore ecology and host resistance mechanisms will further refine outbreak prevention and response strategies.

References

[1] Turnbull PCB. Anthrax in humans and animals. World Health Organization; 2008.

[2] Hugh-Jones ME, de Vos V. Anthrax and wildlife. Rev Sci Tech. 2002;21(1):359-383.

[3] Dragon DC, Rennie RP. The ecology of anthrax spores: tough but not invincible. Can Vet J. 1995;36(5):295-301.

[4] Okinaka RT, Cloud K, Hampton O, et al. Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J Bacteriol. 1999;181(20):6509-6515.

[5] Makino S, Uchida I, Terakado N, et al. Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis. J Bacteriol. 1989;171(2):722-730.

[6] Moayeri M, Leppla SH. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med. 2009;30(6):439-455.

[7] Beyer W, Turnbull PCB. Anthrax in animals. Mol Aspects Med. 2009;30(6):481-489.

[8] Manchee RJ, Broster MG, Melling J, et al. Bacillus anthracis on Gruinard Island. Nature. 1981;294(5838):254-255.

[9] Nicholson WL, Munakata N, Horneck G, et al. Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments. Microbiol Mol Biol Rev. 2000;64(3):548-572.

[10] Driks A. The Bacillus anthracis spore. Mol Aspects Med. 2009;30(6):368-373.

[11] Ireland JA, Hanna PC. Amino acid- and purine ribonucleoside-induced germination of Bacillus anthracis DeltaSterne endospores: gerS mediates responses to aromatic ring structures. J Bacteriol. 2002;184(5):1296-1303.

[12] Gates CC, Elkin BT, Dragon DC. Investigation, control and epizootiology of anthrax in a geographically isolated, free-roaming bison population in northern Canada. Can J Vet Res. 1995;59(4):256-264.

[13] Clegg SB, Turnbull PCB, Foggin CM, et al. Massive outbreak of anthrax in wildlife in the Malilangwe Wildlife Reserve, Zimbabwe. Vet Rec. 2007;160(4):113-118.

[14] Jori F, Etter E, Bengis RG, et al. Anthrax in wildlife in southern Africa: a review. J S Afr Vet Assoc. 2000;71(4):245-250.

[15] Blackburn JK, McNyset KM, Curtis A, et al. Modeling the geographic distribution of Bacillus anthracis, the causative agent of anthrax disease, for the contiguous United States using predictive ecologic niche modeling. Am J Trop Med Hyg. 2007;77(6):1103-1110.

[16] Shury TK, Nishi JS, Elkin BT, et al. Anthrax in free-ranging bison in the Prince Albert National Park area of Saskatchewan in 2008. Can Vet J. 2009;50(2):152-154.

[17] Fasanella A, Garofolo G, Galante D, et al. Severe anthrax outbreaks in Italy in 2004: considerations on factors involved in the spread of infection. New Microbiol. 2005;28(1):79-86.

[18] Houston DC, Cooper JE. The digestive tract of the whiteback griffon vulture and its role in disease transmission among wild ungulates. J Wildl Dis. 1975;11(3):306-313.

[19] Van Ness GB. Ecology of anthrax. Science. 1971;172(3989):1303-1307.

[20] Lindeque PM, Turnbull PCB. Ecology and epidemiology of anthrax in the Etosha National Park, Namibia. Onderstepoort J Vet Res. 1994;61(1):71-83.

[21] Hampson K, Lembo T, Bessell P, et al. Predictability of anthrax infection in the Serengeti, Tanzania. J Appl Ecol. 2011;48(6):1333-1344.

[22] Turner WC, Imologhome P, Havarua Z, et al. Soil ingestion, nutrition and the seasonality of anthrax in herbivores of Etosha National Park. Ecosphere. 2013;4(1):1-19.

[23] Turell MJ, Knudson GB. Mechanical transmission of Bacillus anthracis by stable flies (Stomoxys calcitrans) and mosquitoes (Aedes aegypti and Aedes taeniorhynchus). Infect Immun. 1987;55(8):1859-1861.

[24] Hugh-Jones M. 1996-97 global anthrax report. J Appl Microbiol. 1999;87(2):189-191.

[25] Blackburn JK, Goodin DG. Differentiation of springtime vegetation indices associated with summer anthrax cases in southwest Texas, USA. J Wildl Dis. 2013;49(3):699-703.

[26] Fasanella A, Garofolo G, Hossain MJ, et al. Anthrax in Europe: a review. Vet Ital. 2010;46(4):371-378.

[27] Guidi-Rontani C, Weber-Levy M, Labruyere E, et al. Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol. 1999;31(1):9-17.

[28] Lincoln RE, Hodges DR, Klein F, et al. Role of the lymphatics in the pathogenesis of anthrax. J Infect Dis. 1965;115(5):481-486.

[29] Duesbery NS, Webb CP, Leppla SH, et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 1998;280(5364):734-737.

[30] Leppla SH. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations in eukaryotic cells. Proc Natl Acad Sci USA. 1982;79(10):3162-3166.

[31] Smith H, Keppie J. Observations on experimental anthrax: demonstration of a lethal factor produced in vivo by Bacillus anthracis. Nature. 1954;173(4410):869-870.

[32] de Vos V, Bryden HB. Anthrax in the Kruger National Park: a review. J S Afr Vet Assoc. 1996;67(1):21-25.

[33] Sterne M. The effects of different carbon dioxide concentrations on the growth of virulent anthrax strains. Onderstepoort J Vet Sci Anim Ind. 1937;9(1):49-67.

[34] Turnbull PCB, Doganay M, Lindeque PM, et al. Serology and anthrax in humans, livestock and Etosha National Park wildlife. Epidemiol Infect. 1992;108(2):299-313.

[35] Redmond C, Hall GA, Turnbull PCB, et al. Experimental anthrax in pigs: clinical signs and pathology. Vet Rec. 1996;139(10):235-239.

[36] M'Fadyean J. A peculiar staining reaction of the blood of animals dead of anthrax. J Comp Pathol Ther. 1903;16:35-41.

[37] Dragon DC, Bader DE, Mitchell J, et al. Natural dissemination of Bacillus anthracis spores in northern Canada. Appl Environ Microbiol. 2005;71(3):1610-1615.

[38] Turnbull PCB. Definitive identification of Bacillus anthracis: a review. J Appl Microbiol. 1999;87(2):237-240.

[39] Knisely RF. Selective medium for Bacillus anthracis. J Bacteriol. 1966;92(3):784-786.

[40] World Organisation for Animal Health (OIE). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.1.1: Anthrax. 2021.

[41] Beyer W, Glöckner P, Otto J, et al. A nested PCR method for the detection of Bacillus anthracis in environmental samples collected from former tannery sites. Microbiol Res. 1995;150(2):179-186.

[42] Ellerbrok H, Nattermann H, Ozel M, et al. Rapid and sensitive identification of pathogenic and apathogenic Bacillus anthracis by real-time PCR. FEMS Microbiol Lett. 2002;214(1):51-59.

[43] Wielinga PR, Hamidjaja RA, Agren J, et al. A multiplex real-time PCR for identifying and differentiating B. anthracis virulent types. Int J Food Microbiol. 2011;145(Suppl 1):S137-S144.

[44] Kim K, Seo J, Wheeler K, et al. Rapid genotypic detection of Bacillus anthracis and the Bacillus cereus group by multiplex real-time PCR. J Microbiol Methods. 2005;60(2):203-211.

[45] Qiao YM, Guo YC, Zhang XE, et al. Loop-mediated isothermal amplification for rapid detection of Bacillus anthracis spores. Biotechnol Lett. 2007;29(12):1939-1946.

[46] Quinn CP, Semenova VA, Elie CM, et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis. 2002;8(10):1103-1110.

[47] Turnbull PCB, Broster MG, Carman JA, et al. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect Immun. 1986;52(2):356-363.

[48] World Health Organization. Anthrax in humans and animals. 4th ed. Geneva: WHO Press; 2008.

[49] Watson DJ, Keir D. Anthrax: a guide for veterinarians. In Pract. 1994;16(5):244-250.

[50] Dragon DC, Elkin BT, Nishi JS, et al. A review of anthrax in Canada and implications for research on the disease in northern bison. J Appl Microbiol. 1999;87(2):208-213.

[51] Spotts Whitney EA, Beatty ME, Taylor TH Jr, et al. Inactivation of Bacillus anthracis spores. Emerg Infect Dis. 2003;9(6):623-627.

[52] Rogers JV, Sabourin CL, Choi YW, et al. Decontamination assessment of Bacillus anthracis, Bacillus subtilis, and Geobacillus stearothermophilus spores on indoor surfaces using a hydrogen peroxide gas generator. J Appl Microbiol. 2005;99(4):739-748.

[53] Sterne M. The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Onderstepoort J Vet Sci Anim Ind. 1939;13(2):307-312.

[54] Turnbull PCB. Anthrax vaccines: past, present and future. Vaccine. 1991;9(8):533-539.

[55] Blackburn JK, Odugbo MO, Van Ert M, et al. Bacillus anthracis diversity in Ghana. PLoS One. 2015;10(3):e0118711.

[56] Joyner TA, Lukhnova L, Pazilov Y, et al. Modeling the potential distribution of Bacillus anthracis under multiple climate change scenarios for Kazakhstan. PLoS One. 2010;5(3):e9596.